Recent Finacing
Recent Raise
Engage Therapeutics is a clinical-stage biopharmaceutical company developing Staccato alprazolam, a hand-held inhaled drug-device using Alexza's delivery technology, pursuing FDA 505(b)(2) approval with planned Phase 2b trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors